This section has no associated Explanatory Memorandum
16. Details of any authorisation or registration obtained by the applicant in [F1a country other than the United Kingdom] allowing the medicinal product to be placed on the market.U.K.
Textual Amendments
F1Words in Sch. 12 para. 16 substituted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 115(2); 2020 c. 1, Sch. 5 para. 1(1)